Moving Forward into the New Era of HSCT and Cellular Therapy
Today 2025.01.22 D-End
Today 
Moving Forward into the New Era of HSCT and Cellular Therapy
| Room A (2F) | Room B (2F) | Room C (1F) | Room D (1F) | |||
|---|---|---|---|---|---|---|
| 08:30-09:00 | Satellite Symposium | |||||
 * Coffee and light breakfast box will be provided. |
||||||
| 09:00-10:00 | Oral 5 | Oral 6 | Oral 7 | Oral 8 | ||
| 10:00-10:20 | Break | |||||
| 10:20-11:00 | Plenary Session 3 | |||||
| New Horizons in the Treatment of Acute Myeloid Leukemia | ||||||
| 11:00-11:40 | Presidential Symposium | |||||
| Future Perspectives of HSCT in the Cellular Immunotherapy Era | ||||||
| 11:40-11:50 | Break | |||||
| 11:50-12:30 | Luncheon Symposium 6 | Luncheon Symposium 7 | Luncheon Symposium 8 |
|
||
 |
 |
 |
|
|||
| 12:30-12:40 | Break | |||||
| 12:40-14:10 | Scientific Session 5 | Scientific Session 6 | Education Session 2 | Scientific Session 7 | ||
| Microbiota in Transplantation and Cell Therapy | Optimizing Graft Engineering and Cell Therapy | The Clinical Role of HSCT in Patients with MPN | Innovations in Cellular Therapy and Beyond | |||
| 14:10-14:20 | Break | |||||
| 14:20-15:50 | Joint Symposium 3 (EBMT-KSBMT) |
Debate Session
Kor
Korean-English |
Education Session 3 | Scientific Session 8 | ||
| Disease-specific Issues and Transplantation Outcomes of CBT and HIDT | [DS01] ASCT for Multiple Myeloma Patients with Chronic Kidney Disease [DS02] Upfront HSCT for Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia in Children and Adolescents |
Post-HSCT, Non-hematological Complication and Management | The 30th Anniversary Symposium of KMDP & CHSCB | |||
| 15:50-16:00 | Break | |||||
| 16:00-16:05 | Break | |||||
| 16:05-16:10 | Break | |||||
| 16:10-16:30 | Poster | |||||
| 16:30-16:40 | Joint Symposium 4 (East Asia Collaborative Session) | Break | ||||
| 16:40-18:10 | Autologous Transplantation Strategies for High-risk Myeloma in the East-Asian Countries | Scientific Session 9 | Scientific Session 10 | Education Session 4 | ||
| Advancements in AML and MDS | Regulatory Status of Novel Cell and Gene Therapy | Back to the Basic - Guidelines of Hematopoietic Stem Cell Transplantation | ||||
| 18:45~ | Gala Dinner (Grand Ballroom, Paradise Hotel Busan) |
|||||
| Room A (2F) | Room B (2F) | Room C (1F) | |
|---|---|---|---|
| 07:30-09:00 | KSBMT Business Meeting | ||
| 09:00-10:30 | Joint Symposium 5 (ISCT-KSBMT) | Scientific Session 11 | Scientific Session 12 |
| Current Status and Future Prospect of Artificial Blood Products | Beyond JAK Pathway in GVHD | Current Overview and Pragmatic Challenges in CAR-T Therapeutics | |
| 10:30-10:40 | Break | ||
| 10:40-11:40 | Joint Symposium 6 (TSBMT-KSBMT) | Scientific Session 13 | Nursing Session 2 [Kor] |
| Management of Early Transplantation Complications | Transplantation in Pediatric Leukemia - For the Best Outcomes | Long-Term Follow-Up and Experience with Hematopoietic Stem Cell Transplant Patients II | |
| 11:40-12:10 | Break | ||
| 12:10-12:20 | Break | ||
| 12:20-12:30 | Closing Ceremony | ||
| 12:30-13:00 | KSBMT General Assembly | ||
& Voting will be provided.